Vitalab Pharmacy, Inc. is recalling approximately 265 vials of several sterile injectable drug products, including Methylcobalamin, Alprostadil, and various Papaverine combinations. The recall was initiated because 3rd-party testing showed that the pharmacy's airflow patterns may not have been sufficient to ensure the drugs remained sterile during production. These products were distributed to patients across the United States between late 2017 and early 2018. Using an injectable drug that is not sterile can lead to serious or life-threatening infections.
The lack of proper airflow during the manufacturing process means these injectable medications may have been contaminated with bacteria or other microorganisms. Because these drugs are injected directly into the body, any contamination poses a significant risk of causing systemic infections or abscesses at the injection site.
Drug recall baseline remedy
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.